353255-15-9

Basic information

• Product Name: Benzamide, 2-amino-N-[4-(1-methylethyl)phenyl]- (9CI)
• Synonyms: Benzamide, 2-amino-N-[4-(1-methylethyl)phenyl]- (9CI)
• CAS NO: 353255-15-9
• Molecular Formula: C₁₆H₁₈N₂O
• Molecular Weight: 254.32692
• Product Categories: AMIDE
• Mol File: 353255-15-9.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Benzamide, 2-amino-N-[4-(1-methylethyl)phenyl]- (9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: Benzamide, 2-amino-N-[4-(1-methylethyl)phenyl]- (9CI)(353255-15-9)
• EPA Substance Registry System: Benzamide, 2-amino-N-[4-(1-methylethyl)phenyl]- (9CI)(353255-15-9)

Safety Data

• Hazardous Substances Data: 353255-15-9(Hazardous Substances Data)

Upstream product

• 118-48-9 isatoic anhydride 
• 99-88-7 4-Isopropylaniline 

Downstream Products

• 346421-13-4 3-(4-isopropylphenyl)quinazolin-4(3H)-one 
• 1403986-71-9 4-(4-i-propylphenyl)-1,5-dioxo-1,2,3,3a,4,5-hexahydropyrrolo[1,2-a]quinazoline-3a-carboxylic acid 
• 1422154-65-1 2-((5,5-dimethyl-3-oxocyclohex-1-en-1-yl)amino)-N-(4-isopropylphenyl)benzamide 
• 1235479-96-5 2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-3-(4-isopropylphenyl)quinazolin-4(3H)-one 
• 625379-22-8 N-(4-isopropyl-phenyl)-2-(2,2,2-trichloro-acetylamino)-benzamide 
• 133040-89-8 2-[2-(5-Bromo-1H-indol-3-yl)-ethyl]-3-(4-isopropyl-phenyl)-3H-quinazolin-4-one 

Relevant articles and documents

Ionic liquid supported on magnetic nanoparticles as a novel reusable nanocatalyst for the efficient synthesis of tetracyclic quinazoline compounds

A magnetic ionic liquid supported on γ-Fe2O3 nanocatalyst was synthesized successfully and characterized by Fourier transform infrared spectroscopy, vibrating sample magnetometry, thermogravimetric analysis, differential scanning calorimetry, X-ray diffraction and scanning electron microscopy. The resulting nano-Fe3O4-supported, ionic liquid was an efficient catalyst for preparation of a series of tetracyclic quinazoline compounds by three components reaction of a mixture of isatoic anhydride and amine with ninhydrin in PEG and the desired products were obtained in good to excellent yields. High efficiency, waste-free, mild reaction conditions, effortless magnetic recovery and reusability up to four continuous cycles are the noteworthy features of the currently employed heterogeneous catalytic system.

COMPOUNDS FOR THE PREVENTION AND TREATMENT OF CARDIOVASCULAR DISEASE

Disclosed are novel compounds that are useful for regulating the expression of apolipoprotein A-I (ApoA-l), and their use for the treatment and prevention of cardiovascular disease and related disease states, including cholesterol- or lipid-related disorders, such as, for example, atherosclerosis. Also disclosed are pharmaceutical compositions comprising the novel compounds.

Quinazolinone cholecystokinin-B receptor ligands [2]

-